•
LC
Lee Cooper
Managing Director at Delos Capital
Greater Boston
Overview
Lee Cooper is a highly accomplished professional with a background in life sciences ventures, teaching, and advocacy. Currently serving as the Managing Director at Delos Capital, Lee has also held key roles at Leaps by Bayer and Moderna Therapeutics, showcasing expertise in venture investments and business development within the healthcare sector.
With a J.D. from Columbia Law School and an MBA from Columbia Business School, Lee has a strong academic foundation that complements over a decade of experience in strategic roles, including serving as a Faculty Lecturer at Thayer School of Engineering at Dartmouth and as an Associate Director at Moderna Therapeutics.
Work Experience
Managing Director
2024 - Current
Faculty Lecturer
2021
ENGS 15.03 - Ecosystem for Bio-Innovation
Lecturer
2022
Bio 196 - Exploratory Topics in Biology
Director, Venture Investments
2020 - 2024
Investments and/or board service include: Capstan Therapeutics, Recursion ($RXRX), Gandeeva Therapeutics, Senti Bio ($SNTI), Ukko, Pyxis ($PYXS), Cellino, Triumvira, Ukko, Century Tx ($IPSC), Ada Health, others
Entrepreneur In Residence
2018 - 2019
Biotech venture formation and investment diligence.
RA Capital Management is an investment advisor specializing in the life-sciences and drug development sectors.
Founder
2018 - 2019
Patient-centered genomics company formed with support from RA Capital.
Associate Director, Business Development
2015 - 2017
Partnerships and financing to advance vaccines and therapeutics in infectious disease, oncology, and rare genetic disease.
Technology and Life Sciences Practice
2014 - 2014
Goodwin Procter provides corporate law and litigation services.
Strategy Consultant
2009 - 2012
Director of International Programs
2009 - 2009